SPON1 is an independent prognostic biomarker for ovarian cancer

BACKGROUND: Ovarian cancer has the worst outcome among gynecological malignancies; therefore, biomarkers that could contribute to the early diagnosis and/or prognosis prediction are urgently required. In the present study, we focused on the secreted protein spondin-1 (SPON1) and clarified the progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyakawa, Ryoya, Kobayashi, Makoto, Sugimoto, Kotaro, Endo, Yuta, Kojima, Manabu, Kobayashi, Yasuyuki, Furukawa, Shigenori, Honda, Tsuyoshi, Watanabe, Takafumi, Asano, Shigeyuki, Soeda, Shu, Hashimoto, Yuko, Fujimori, Keiya, Chiba, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182672/
https://www.ncbi.nlm.nih.gov/pubmed/37179355
http://dx.doi.org/10.1186/s13048-023-01180-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182672/
https://www.ncbi.nlm.nih.gov/pubmed/37179355
http://dx.doi.org/10.1186/s13048-023-01180-8

Ejemplares similares